Prognyx oncology intelligence
Live ClinicalTrials.gov oncology trial comparison around an asset, plus landscapes and CI briefings.
Should I use this
Quality & Safety
Based on automated analysis of tool definitions and protocol compliance.
Context Cost
This is the approximate number of tokens consumed each time the server's tools are loaded into a model's context. Higher counts reduce the attention available for other tasks.
Install
One-Click Install
Add this to your `claude_desktop_config.json` file:
{
"mcpServers": {
"oncology-intelligence": {
"url": "https://www.prognyx.com/api/mcp"
}
}
}Remote endpoints
https://www.prognyx.com/api/mcpstreamable-httpWhat it can do
Tool inventory
Tools (3)
🟢compare_trials(asset, indication)
Up to three interventional ClinicalTrials.gov studies matching an asset or target AND an oncology indication, side by side: sponsor, phase, status, declared arms, primary outcomes, last update, registry URL. Active studies first, then later phase; different sponsors where possible. Use a target (e.g. "KIF18A", "B7-H3") rather than one drug name to see other programmes.
Input Schema
{
"type": "object",
"properties": {
"asset": {
"type": "string",
"maxLength": 80,
"description": "Public asset or target, e.g. \"sotorasib\", \"KRAS G12C\", \"B7-H3\"."
},
"indication": {
"type": "string",
"maxLength": 80,
"description": "Oncology indication, e.g. \"colorectal cancer\", \"NSCLC\"."
}
},
"required": [
"asset",
"indication"
],
"additionalProperties": false
}🟢search_registry(query, limit)
Live landscape for a target, asset, company, indication or NCT number: total and active study counts, leading sponsors, phase mix, the most recently updated studies with URLs, and related Prognyx briefings. Counts for phases and sponsors come from a recent sample, stated in the result.
Input Schema
{
"type": "object",
"properties": {
"query": {
"type": "string",
"maxLength": 160,
"description": "e.g. \"KRAS G12C\", \"Nuvalent\", \"claudin 18.2 gastric cancer\", \"NCT05132075\"."
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 25,
"default": 10,
"description": "Studies to return."
}
},
"required": [
"query"
],
"additionalProperties": false
}🟢search_briefings(query, limit)
Prognyx oncology competitive-intelligence briefings (each claim linked to a primary source) matching a drug, company, target or indication, newest first, with URL, date and summary.
Input Schema
{
"type": "object",
"properties": {
"query": {
"type": "string",
"maxLength": 120,
"description": "Drug, company, target or indication. Empty returns the latest."
},
"limit": {
"type": "integer",
"minimum": 1,
"maximum": 20,
"default": 5,
"description": "Briefings to return."
}
},
"additionalProperties": false
}Community
Evidence